company background image
4009 logo

Middle East Healthcare SASE:4009 Voorraadrapport

Laatste prijs

ر.س71.00

Marktkapitalisatie

ر.س6.6b

7D

-6.0%

1Y

13.1%

Bijgewerkt

03 Oct, 2024

Gegevens

Financiële gegevens bedrijf +

Middle East Healthcare Company

SASE:4009 Voorraadrapport

Marktkapitalisatie: ر.س6.6b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

4009 Overzicht aandelen

Middle East Healthcare Company, een aanbieder van gezondheidszorg, bezit en exploiteert een netwerk van ziekenhuizen onder de naam Saudi German Hospital in het Midden-Oosten en Noord-Afrika.

Middle East Healthcare Company Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Middle East Healthcare
Historische aandelenkoersen
Huidige aandelenkoersر.س71.00
52 Week Hoogtepuntر.س134.40
52 Week Laagر.س58.70
Bèta0.42
11 maand verandering-5.33%
3 maanden verandering-17.25%
1 Jaar Verandering13.06%
33 jaar verandering90.09%
5 jaar verandering168.43%
Verandering sinds IPO-0.70%

Recent nieuws en updates

Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Sep 24
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Sep 24
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

Jul 18
Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

May 30
There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Apr 29
If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

Apr 02
Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Feb 11
There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Feb 08
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Jan 18
Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Dec 28
Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Sep 26
Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Jun 28
Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Mar 30
Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Sep 20
Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Jun 14
Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Apr 18
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Aug 10
Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

Mar 29
Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Mar 03
An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 10
Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

Jan 23
Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Jan 05
If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Dec 18
Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Nov 30
Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Rendement voor aandeelhouders

4009SA HealthcareSA Markt
7D-6.0%-4.9%-2.4%
1Y13.1%15.2%-9.9%

Rendement versus industrie: 4009 presteerde slechter dan de SA Healthcare -sector, die het afgelopen jaar een rendement van 15.8 % opleverde.

Rendement versus markt: 4009 overtrof de SA markt, die het afgelopen jaar een rendement opleverde van -11.2 %.

Prijsvolatiliteit

Is 4009's price volatile compared to industry and market?
4009 volatility
4009 Average Weekly Movement5.8%
Healthcare Industry Average Movement4.9%
Market Average Movement4.5%
10% most volatile stocks in SA Market7.7%
10% least volatile stocks in SA Market2.7%

Stabiele aandelenkoers: De aandelenkoers van 4009 is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van 4009 is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen SA.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1988n/aAhmed Mohamed Al-Atrissaudigermanhealth.com

Middle East Healthcare Company, een leverancier van gezondheidszorg, bezit en beheert een netwerk van ziekenhuizen onder de naam Saudi German Hospital in het Midden-Oosten en Noord-Afrika. Het bedrijf exploiteert, beheert en onderhoudt ook medische en educatieve centra, revalidatiecentra, fysiotherapie, apotheken, laboratoria en radiologiecentra. Het bedrijf koopt ook grond om medische projecten te bouwen en om tentoonstellingen op te zetten, te beheren, te bouwen en te organiseren.

Middle East Healthcare Company Samenvatting

Hoe verhouden de winst en inkomsten van Middle East Healthcare zich tot de beurswaarde?
4009 fundamentele statistieken
Marktkapitalisatieر.س6.63b
Inkomsten(TTM)ر.س202.92m
Inkomsten(TTM)ر.س2.79b

32.2x

Koers/Winstverhouding

2.3x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
4009 resultatenrekening (TTM)
Inkomstenر.س2.79b
Kosten van inkomstenر.س1.70b
Brutowinstر.س1.09b
Overige uitgavenر.س885.61m
Inkomstenر.س202.92m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)2.20
Brutomarge38.98%
Nettowinstmarge7.27%
Schuld/Eigen Vermogen Verhouding146.2%

Hoe presteerde 4009 op de lange termijn?

Bekijk historische prestaties en vergelijking